472 related articles for article (PubMed ID: 30550750)
21. Impaired contractile function due to decreased cardiac myosin binding protein C content in the sarcomere.
Cheng Y; Wan X; McElfresh TA; Chen X; Gresham KS; Rosenbaum DS; Chandler MP; Stelzer JE
Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H52-65. PubMed ID: 23666674
[TBL] [Abstract][Full Text] [Related]
22. Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.
Flenner F; Geertz B; Reischmann-Düsener S; Weinberger F; Eschenhagen T; Carrier L; Friedrich FW
J Physiol; 2017 Jun; 595(12):3987-3999. PubMed ID: 28090637
[TBL] [Abstract][Full Text] [Related]
23. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
[TBL] [Abstract][Full Text] [Related]
24. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy.
Carrier L; Bonne G; Bährend E; Yu B; Richard P; Niel F; Hainque B; Cruaud C; Gary F; Labeit S; Bouhour JB; Dubourg O; Desnos M; Hagège AA; Trent RJ; Komajda M; Fiszman M; Schwartz K
Circ Res; 1997 Mar; 80(3):427-34. PubMed ID: 9048664
[TBL] [Abstract][Full Text] [Related]
25. Mavacamten rescues increased myofilament calcium sensitivity and dysregulation of Ca
Sparrow AJ; Watkins H; Daniels MJ; Redwood C; Robinson P
Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H715-H722. PubMed ID: 32083971
[TBL] [Abstract][Full Text] [Related]
26. Myosin binding protein-C activates thin filaments and inhibits thick filaments in heart muscle cells.
Kampourakis T; Yan Z; Gautel M; Sun YB; Irving M
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18763-8. PubMed ID: 25512492
[TBL] [Abstract][Full Text] [Related]
27. In vivo modeling of myosin binding protein C familial hypertrophic cardiomyopathy.
Yang Q; Sanbe A; Osinska H; Hewett TE; Klevitsky R; Robbins J
Circ Res; 1999 Oct; 85(9):841-7. PubMed ID: 10532952
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the effects of a truncating and a missense MYBPC3 mutation on contractile parameters of engineered heart tissue.
Wijnker PJ; Friedrich FW; Dutsch A; Reischmann S; Eder A; Mannhardt I; Mearini G; Eschenhagen T; van der Velden J; Carrier L
J Mol Cell Cardiol; 2016 Aug; 97():82-92. PubMed ID: 27108529
[TBL] [Abstract][Full Text] [Related]
29. Phosphomimetic cardiac myosin-binding protein C partially rescues a cardiomyopathy phenotype in murine engineered heart tissue.
Dutsch A; Wijnker PJM; Schlossarek S; Friedrich FW; Krämer E; Braren I; Hirt MN; Brenière-Letuffe D; Rhoden A; Mannhardt I; Eschenhagen T; Carrier L; Mearini G
Sci Rep; 2019 Dec; 9(1):18152. PubMed ID: 31796859
[TBL] [Abstract][Full Text] [Related]
30. Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice.
Fraysse B; Weinberger F; Bardswell SC; Cuello F; Vignier N; Geertz B; Starbatty J; Krämer E; Coirault C; Eschenhagen T; Kentish JC; Avkiran M; Carrier L
J Mol Cell Cardiol; 2012 Jun; 52(6):1299-307. PubMed ID: 22465693
[TBL] [Abstract][Full Text] [Related]
31. Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
Robinson P; Griffiths PJ; Watkins H; Redwood CS
Circ Res; 2007 Dec; 101(12):1266-73. PubMed ID: 17932326
[TBL] [Abstract][Full Text] [Related]
32. How do MYBPC3 mutations cause hypertrophic cardiomyopathy?
Marston S; Copeland O; Gehmlich K; Schlossarek S; Carrier L
J Muscle Res Cell Motil; 2012 May; 33(1):75-80. PubMed ID: 22057632
[TBL] [Abstract][Full Text] [Related]
33. A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction.
Kuster DW; Govindan S; Springer TI; Martin JL; Finley NL; Sadayappan S
J Biol Chem; 2015 Feb; 290(9):5855-67. PubMed ID: 25583989
[TBL] [Abstract][Full Text] [Related]
34. Structural and Functional Effects of Cardiomyopathy-Causing Mutations in the Troponin T-Binding Region of Cardiac Tropomyosin.
Matyushenko AM; Shchepkin DV; Kopylova GV; Popruga KE; Artemova NV; Pivovarova AV; Bershitsky SY; Levitsky DI
Biochemistry; 2017 Jan; 56(1):250-259. PubMed ID: 27983818
[TBL] [Abstract][Full Text] [Related]
35. Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice.
Najafi A; Schlossarek S; van Deel ED; van den Heuvel N; Güçlü A; Goebel M; Kuster DW; Carrier L; van der Velden J
Pflugers Arch; 2015 Jun; 467(6):1303-17. PubMed ID: 25010737
[TBL] [Abstract][Full Text] [Related]
36. Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy.
Erdmann J; Daehmlow S; Wischke S; Senyuva M; Werner U; Raible J; Tanis N; Dyachenko S; Hummel M; Hetzer R; Regitz-Zagrosek V
Clin Genet; 2003 Oct; 64(4):339-49. PubMed ID: 12974739
[TBL] [Abstract][Full Text] [Related]
37. Ablation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes.
McNamara JW; Li A; Smith NJ; Lal S; Graham RM; Kooiker KB; van Dijk SJ; Remedios CGD; Harris SP; Cooke R
J Mol Cell Cardiol; 2016 May; 94():65-71. PubMed ID: 27021517
[TBL] [Abstract][Full Text] [Related]
38. Cardiac myosin binding protein C: its role in physiology and disease.
Flashman E; Redwood C; Moolman-Smook J; Watkins H
Circ Res; 2004 May; 94(10):1279-89. PubMed ID: 15166115
[TBL] [Abstract][Full Text] [Related]
39. Altered C10 domain in cardiac myosin binding protein-C results in hypertrophic cardiomyopathy.
Kuster DWD; Lynch TL; Barefield DY; Sivaguru M; Kuffel G; Zilliox MJ; Lee KH; Craig R; Namakkal-Soorappan R; Sadayappan S
Cardiovasc Res; 2019 Dec; 115(14):1986-1997. PubMed ID: 31050699
[TBL] [Abstract][Full Text] [Related]
40. MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy.
McNamara JW; Li A; Lal S; Bos JM; Harris SP; van der Velden J; Ackerman MJ; Cooke R; Dos Remedios CG
PLoS One; 2017; 12(6):e0180064. PubMed ID: 28658286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
